Chair of the Board · Protagonist Therapeutics, Inc (PTGX)

Chair, Nominating/Governance Committee

Harold E. Selick, Ph.D director compensation at Protagonist: $428K

Fiscal year 2025 director compensation for Harold E. Selick, Ph.D at Protagonist Therapeutics, Inc. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Harold E. Selick, Ph.D’s full pay file as a PDF — free

More than this page: up to 10 years of Harold’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Harold E. Selick, Ph.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Protagonist Therapeutics Director Compensation Table · all 4 fiscal years held
In US dollars, as Protagonist Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$28,266$199,967$199,833$0$428,066
FY2024$100,000—$471,734$0$571,734
FY2022$95,000—$128,940—$223,940
FY2021$95,000—$448,011—$543,011

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Protagonist Therapeutics, Inc DEF 14A filed April 28, 2026, accession 0001104659-26-050429, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Protagonist Therapeutics, Inc filed document, accession 0001104659-26-050429. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

Get the Protagonist Therapeutics Board Governance Report

$428,066 Harold E. Selick, Ph.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 28, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Protagonist Therapeutics pays directors a $45,000 cash retainer and $400,000 in equity.

Committees

FY2025 · as the proxy prints them

Compensation · Nominating/Governance (Chair) · Research

The rest of the Protagonist Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Bryan GiraudoIndependent Director$431,816
Dinesh V. Patel, Ph.DDirector—
Lewis T. Williams, M.D., Ph.DIndependent Director$431,816
Sarah A. O'DowdDirector$436,517
William D. WaddillIndependent Director$431,816

The full Protagonist Therapeutics compensation record

free company brief

This page is one director within Protagonist Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Protagonist Therapeutics proxy · each links to its own free brief

Order PTGX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report